Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01848184 · ClinicalTrials.gov registry record
A Prospective Study in Patients Undergoing Primary Ventral Hernia Repair Using Parietex™ Composite Ventral Patch
A clinical trial, sponsored by Medtronic - MITG.
- Completed
- Registry status
- 126
- Enrollment target
NCT01848184 is a clinical trial that has completed, run by Medtronic - MITG. The registered enrollment target is 126 participants.
The verdict
NCT01848184 has completed, sponsored by Medtronic - MITG.
- COMPLETED
- Registry status
- 126 participants
- Enrollment target
Study Summary
The objective of this study is to assess the recurrence rate following the use of PARIETEX™ Composite Ventral Patch in primary ventral hernia repair by open approach with intra-peritoneal positioning.
Interventions
- DEVICE PARIETEX™ Composite Ventral Patch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2013-05 |
| Est. Completion | 2016-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01848184
The ClinicalTrials.gov registry entry for NCT01848184 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 126 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic - MITG, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PARIETEX™ Composite Ventral Patch is the first listed.
NCT01848184 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01848184 about?
NCT01848184 is a clinical study titled "A Prospective Study in Patients Undergoing Primary Ventral Hernia Repair Using Parietex™ Composite Ventral Patch". The objective of this study is to assess the recurrence rate following the use of PARIETEX™ Composite Ventral Patch in primary ventral hernia repair by open approach with intra-peritoneal positioning.
What is the current status of trial NCT01848184?
This trial is currently completed. The enrollment target is 126 participants. The study started on 2013-05. Estimated completion is 2016-07.
What interventions are being tested in trial NCT01848184?
The interventions under investigation include: PARIETEX™ Composite Ventral Patch (DEVICE).
Who is sponsoring clinical trial NCT01848184?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.